NCT04023383View on ClinicalTrials.gov

New Cross Linked Hyaluronan Gel After Deep Infiltrating Endometriosis Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 1, 2019

Study Completion Date

June 1, 2019

Conditions
EndometriosisAdhesionQuality of LifeSurgery
Interventions
DRUG

40 cc HyaRegen NCH gel

After an extensive bleeding control the patients in the intervention group had 40 mL of HyaRegen NCH gel instilled into the peritoneal cavity.

DRUG

40 cc sterile saline solution

After an extensive bleeding control the patients in the control group had 40 cc sterile saline solution compatible with the body temperature.

All Listed Sponsors
lead

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

OTHER_GOV

NCT04023383 - New Cross Linked Hyaluronan Gel After Deep Infiltrating Endometriosis Surgery | Biotech Hunter | Biotech Hunter